Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.
Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinical...
Saved in:
Main Authors: | Beatrice Bachmeier, Iduna Fichtner, Peter H Killian, Emanuel Kronski, Ulrich Pfeffer, Thomas Efferth |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/f2440a68bebd4698b08b8cc0c323a8d9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Internalized Nanoceria Modify the Radiation-Sensitivity Profile of MDA MB231 Breast Carcinoma Cells
by: Emory Bibb, et al.
Published: (2021) -
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line
by: Neelam Mishra, et al.
Published: (2021) -
Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
by: Buchegger,Kurt, et al.
Published: (2016) -
Isolation of Breast Cancer Stem Cell from MDA-MB231 Cell Line Using Vincristine
by: Ghanbari,Tara, et al.
Published: (2016) -
An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231)
by: Gurunathan S, et al.
Published: (2014)